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     Abstract:  The population of the Mauritian pink pigeon (Nesoenas mayeri) fell to fewer 
than 20 individuals in the 1970s. Following intensive conservation efforts, the free-living 
population is now estimated to be 470 individuals. However, due to the population bottleneck 
the species remains at risk of extinction due to genetic loss and inbreeding depression. A 
European captive population was established in 1977 and a European Endangered Species 5 
Program (EEP) was formalized in 1992. As birds in the EEP captive population possess 
unique alleles not observed in the surviving free-living birds, the EEP management plan 
recommends transferring EEP birds to Mauritius to improve genetic diversity. Health 
screening of the current EEP population to identify circulating pathogens was performed. 
Forty-two birds from three collections in the UK and one in Jersey were screened for a wide 10 
range of pathogens, present clinically or subclinically, including important viruses, bacteria, 
protozoa and helminths. Eleven birds tested positive for at least one pathogen: Trichomonas 
spp. (5), Yersinia kristensenii (2), Yersinia aleksiciae (1), coccidial oocysts (3) and strongyle 
ova (3). None of the positive birds showed overt signs of clinical disease, although two birds 
with Trichomonas spp. had suboptimal body condition. Genotyping of one T. gallinae sample 15 
revealed a type C strain (low pathogenicity). The results from this screening will contribute 
towards a disease risk assessment, to create a pre-export protocol for translocation of captive 
EEP birds to Mauritius.  
 
     Key words: Columbiformes, disease risk assessment, health screen, Nesoenas mayeri, 20 
pink pigeon, Trichomonas gallinae 
  




     The Mauritian pink pigeon (Nesoenas mayeri) is a recovered bottleneck species.44 The 
population fell to less than 20 individuals in the 1970s,73,74 leading to the establishment in 
1977 of a recovery program by the Mauritian Wildlife Foundation (MWF) and the Durrell 
Wildlife Conservation Trust (DWCT – formerly Jersey Wildlife Preservation Trust). 
Alongside in situ conservation efforts, captive breeding populations were established on 30 
Mauritius and at DWCT headquarters in Jersey.36 This European captive population has been 
managed as a European Endangered Species Program (EEP) since 1992.  By January 2020 
the free-living population had recovered to 470 individuals (Tatayah, pers comm.). One 
major concern for ongoing recovery is reduced genetic variation, inbreeding depression and 
loss of adaptive potential.75 Research shows genetic variation in the captive EEP pink pigeon 35 
population that is absent from the free-living population (Jackson et al., unpubl. data.) and 
therefore translocation of EEP pink pigeons to the captive breeding colony in Mauritius is 
planned.29 Their progeny will be released, with the aim of increasing genetic diversity and 
creating a more sustainable free-living population.  
 40 
     Species reintroductions and conservation translocations have been utilised worldwide with 
increasing frequency in recent years.11,12,31,46 The success of any conservation translocation 
may depend on measures implemented to control the spread of disease associated with 
movement of hosts. When originating from an ex situ population, there is a possibility that 
translocated individuals could carry infectious agents novel to the final destination, and be 45 
introduced as symptomless carriers.37 The International Union for Conservation of Nature 
Guidelines for Reintroductions and Translocations highlight the importance of considering 
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transmissible diseases, and the benefits of performing a disease risk assessment (DRA) to 
maximize the health of translocated animals and minimize the risk of introducing novel 
pathogens to the destination population.41 50 
 
     Columbiformes are susceptible to a variety of infectious diseases.22,35,61 Trichomonosis, 
caused by Trichomonas gallinae and leucocytozoonosis, caused by Leucocytozoon 
marchouxi are two parasitic diseases of concern that have been observed in the Mauritian 
captive and free-living pink pigeon populations.14,59 Trichomonosis has been responsible for 55 
high squab mortality and is believed to be a threat to the species’ recovery.16,73,74 Previous 
studies on L. marchouxi infection in pink pigeons show prevalence of 18.3-30%,14,76 with 
reports of reduction in survival of infected birds.14 Plasmodium spp. and Hemoproteus spp. 
have also caused mortality in many species of wild and captive birds,13,24,48,56 with 
Plasmodium spp. being implicated in the significant decline of native Hawaiian forest 60 
birds.6,7 These hemoparasites are reported in Columbiformes25,67 and have been detected in 
Mauritian birds, but not specifically in pink pigeons.58 Infected Columbiformes are often 
asymptomatic, however, clinical disease can be seen in young, debilitated individuals.35 
 
     Several viruses can infect Columbiformes. Pox viruses are not fatal to all avian species but 65 
may reduce population viability. Avian pox has been detected in Mauritius causing mortality 
in fodies (Foudia rubra),23 and 10% of pink pigeons assessed on Il aux Aigrettes were found 
to be suffering from pox virus.73 Avian pox is believed to be a factor in the decline of bird 
populations in Hawaii, the Galapagos Islands and New Zealand.6,33,57 Increasing frequency 
and appearance in previously unaffected species worldwide, suggests this is an emerging 70 
viral disease.50,60 Many viruses cause immunosuppression and an increased susceptibility to 
pathogens, particularly in young birds.35,71 Pigeon circovirus, adenovirus and herpesvirus are 
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widespread, can have significant immunosuppressive effects and have been found 
concomitantly with young pigeon disease syndrome (YPDS).26,27,35,71 Mortality rate is 
suggested to be around 20% and pigeon circovirus is believed to play an important role in 75 
this multifactorial disease.26 Different variants of pigeon adenovirus exist and have been 
found in clinically healthy domestic pigeons (Columba livia).77 There are several serotypes of 
paramyxoviruses, with avian paramyxovirus-1 (APMV-1) and avian paramyxovirus-7 
reported to infect pigeons.1 Pigeon paramyxovirus-1 (PPMV-1) is a variant of APMV-1. 
Morbidity is usually high, whilst mortality varies with strain.39  80 
 
     Several bacterial diseases can affect Columbiformes. Salmonellosis, most often caused by 
Salmonella typhimurium, is one of the most important.35,39 Many infected birds remain long-
term carriers, excreting bacteria intermittently in the faeces. Chlamydia psittaci, is a zoonotic 
disease found worldwide in a variety of avian species.35,45,70 In pigeons it is often a chronic 85 
disease but can cause epizootic infections.70 Mycobacterium avium and Yersinia 
pseudotuberculosis have a worldwide distribution, are commonly reported as pathogens in 
Europe, and can persist a long time in environmental and animal reservoirs.18,30 Both have 
caused significant mortality in European captive pink pigeons.68  
 90 
     A large number of endoparasites and ectoparasites can cause disease in 
Columbiformes.35,39 Many are found at low levels in clinically healthy birds with disease 
occurring when individuals are immunocompromised or environmental conditions allow 
parasitic load to increase.  
 95 
     This health screen was performed to identify potential pathogens currently present in the 
EEP pink pigeon population. Information obtained will contribute directly to the DRA for the 
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reintroduction, and the subsequent creation of the pre-export testing protocol for the 
translocation of EEP birds to Mauritius.  
 100 
MATERIALS AND METHODS 
 
     The study was approved by the Animal Welfare and Ethical Review Board (AWERB) of 
the University of Bristol Veterinary School.  
 105 
     To formulate a list of potential pathogens a literature search on reported diseases in 
captive and wild Columbiformes was performed with the use of BIOSIS, CAB 
ABSTRACTS, and MEDLINE databases. This focused mainly on diseases in the UK and 
Channel Islands (from where the first cohort of birds will be transferred) but also considered 
emerging infectious diseases reported globally.64 Infectious diseases identified in a 110 
retrospective mortality review of the European captive pink pigeon population were also 
taken into consideration.68 Based on these results a list of diseases to be screened was 
formulated (Table 1). Some pathogens were not tested due to one or more of the following 
reasons: low risk of the pathogen causing clinical disease; lack of availability of commercial 
tests; lack of information relating to the current strain; limitations of handling and sampling 115 
small birds.  
 
     The study population consisted of all EEP pink pigeons (69 birds) during July 2017 – 
April 2018. Exclusions from this population included unfledged birds or any other reason for 
withdrawal by the housing collection. A total of 42/69 birds (61%) were screened across four 120 
collections in the UK and Jersey during this 10-month period. Most screening (69%) took 
place during the winter months (November – February). 
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     Thirty-three birds were sampled conscious, coinciding with routine handling for health 
checks, nail clipping or moving aviaries. Sampling was performed on nine birds whilst 125 
anesthetized for routine health checks. General anesthesia was induced with inhalation of 5% 
isoflurane (Isoflo, Zoetis, Leatherhead, Surrey, KT22 7LP, UK) vaporized in 1.5L/min 
oxygen and maintained using 1-3% isoflurane vaporized in 1.5 L/min oxygen, either via a 
mask or after intubation with a 2.5mm stepped endotracheal tube.  
 130 
     37/42 birds were weighed. 31/42 birds were given a body condition score (BCS) using a 
subjective scale of 1-9, with 1 being emaciated, 9 being obese, and 5 being optimal. All birds 
received a clinical examination, including a visual inspection for evidence of ectoparasites 
and cutaneous lesions characteristic for pigeon pox virus. Oral examination was performed to 
look for lesions suggestive of the diphtheritic form of pox or T. gallinae infection. Nail 135 
clipping was performed if required.  
 
     Venepuncture was performed using the medial metatarsal or ulnar veins with a maximum 
of 0.5ml per 100g body weight taken using a 1ml syringe attached to a 25-27G needle. 
Digital pressure was applied after sampling to encourage hemostasis. Serum samples (200µl) 140 
were submitted for PPMV-1 and APMV-1 hemagglutination-inhibition tests (HIAT: Animal 
and Plant Health Agency, Weybridge, Surrey, KT15 3NB, UK). A minimum of 50µl whole 
blood was placed into 1ml of 96% ethanol for hemoparasite detection. For the polymerase 
chain reaction (PCR) based assays, DNA was isolated from blood samples following a salt 
extraction protocol62 and diluted to 20 ng/µl. The PCR viability of the DNA samples was first 145 
confirmed using a PCR based sexing protocol for birds.32 Only samples successfully 
amplifying a pink pigeon DNA fragment with this method were then used in the pathogen 
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screening. Samples were screened for presence/absence of hemoparasite infection using the 
nested PCR method previously described.38 In order to further control for false negatives, 
samples were screened twice for both Hemoproteus-Plasmodium infection and 150 
Leucocytozoon infection. Light microscope examination (x400 and x1000) of Diff-quik 
(Rapi-Diff II Stain Kit, AtomScientific, Hyde, Cheshire, SK14 4GX, UK) stained blood 
smears was also performed to screen for hemoparasites. 50-100µl whole blood was used to 
saturate a paper disk for C. psittaci serology using the Immunocomb: Avian C. psittaci Ab. 
Test Kit (Biogal Galed Labs Asc Ltd., Kibbutz Galed, 1924000, Israel) according to the 155 
manufacturer’s protocol. When only a small amount of blood could be collected, tests were 
prioritised as follows: hemoparasite PCR and microscopy, C. psittaci, PPMV-1, APMV-1. 
Residual whole blood (up to 100µl) was stored in 0.5-1ml of RNAlater for future genetic 
testing. 
 160 
     PCR testing was performed for C. psittaci (combined conjunctival, choanal & cloacal 
swab), M. avium (combined pharyngeal & cloacal swab), pigeon circovirus (cloacal swab) 
and pigeon herpesvirus (pharyngeal swab). Swabs were sent to Animal Genetics (St Austell, 
Cornwall, PL25 3LB, UK). A selective culture medium for the detection of Trichomonas 
vaginalis (TV pouch: InPouch® Trichomonas vaginalis culture kit, BioMed Diagnotics, Inc., 165 
White City, Oregon, 97503, USA), was used to screen for trichomonads, as previously used 
to culture T. gallinae from Columbiformes.20,34 A crop swab was placed in the top chamber 
of the pouch and viewed immediately under a light microscope (x100 and x400). The double-
chambered pouch was then mixed to allow the sample to disperse into the lower chamber and 
incubated at 37°C. The pouch was viewed every 24 hours for 5-days, for the presence of 170 
motile trichomonads. For positive TV pouches, a stabilate for the isolate was obtained, 
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revived and cultured as previously described.4 Genotyping was performed using the method 
described by Chi et al 2013.20  
 
     A 3-day pooled fecal sample was collected for endoparasite screening. Fecal flotation was 175 
performed using zinc sulphate solution and samples were examined using light microscopy 
(x100 and x400) either at BZG or DWCT by an experienced technician. A cloacal swab or 3-
day pooled fecal sample was cultured for Yersinia spp. and Salmonella spp. (Greendale 
Veterinary Diagnostics Limited, Woking, GU21 2EP, UK). To test for Salmonella spp., XLD 
agar and selentine broth were inoculated with feces and incubated at 37°C overnight. XLD 180 
plates were examined for non-lactose fermenting (NLF) colonies. The selentine broth was 
subcultured onto an XLD agar plate, incubated and examined as above. To test for Yersinia 
spp., Yersinia Selective Agar was inoculated with feces. This was incubated aerobically at 
30°C for 48 hours, checking for growth each day. Any suspect colonies were subcultured 
onto blood agar and MacConkeys agar plates for further investigation. For positive samples, 185 
the species was identified using matrix-assisted laser desorption/ionization - time of flight 
mass spectroscopy (MALDI-ToF). Variation in sampling method (cloacal swab or pooled 
fecal sample) was due to addition of this test part way through the study period.   
 
A summary of testing requirements for each disease can be seen in Table 1.   190 
 
RESULTS 
      
Of the 42 birds sampled there were 18 females and 24 males, confirmed by molecular sexing. 
Age ranged from 1 month 18 days to 12 years 7 months. Twenty-three birds were juveniles 195 
(31 days –  1-year-old) and 19 birds were adults  1-year-old. The median age was 9 
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months and 27 days. All birds screened were negative for pigeon circovirus, pigeon 
herpesvirus, PPMV-1, APMV-1, C. psittaci, M. avium, Salmonella spp., Leucocytozoon spp., 
Plasmodium spp. and Hemoproteus spp.. 26.2% (7 males, 4 females) tested positive for at 
least one of the following: T. gallinae (5), coccidial oocysts (3), strongyle ova (3) and 200 
Yersinia spp. (Yersinia kristensenii (2) and Yersinia aleksiciae (1)). All Yersinia spp. cultured 
were obtained from cloacal swabbing. One bird had co-infection with T. gallinae and Y. 
aleksiciae. Two birds had co-infection with coccidial oocysts and strongyle ova. None of 
these birds showed overt signs of clinical disease. Not all birds were screened for every 
disease due to challenges with obtaining enough blood volume, the addition of extra testing 205 
after the health screening had commenced and tests being run in batches (Table 1). 
 
     Weight ranged from 200g – 392g. BCS ranged from 3-5/9. Most birds had an optimal 
BCS (5/9). 3/31 were BCS 4-5/9, which was deemed acceptable. 4/31 birds had a suboptimal 
BCS (3/9). Three were under 5 months old and one over 12 years old. Nineteen birds had 210 
overgrown nails (45.2%). Two birds had deformed keels (laterally deviated), four had foot 
abnormalities (pododermatitis, missing nails, toe injuries), seven had poor plumage (broken 
primaries and tail feathers) and three had evidence of skin trauma (scalping injury, carpal 
abrasions). No birds had visible pigeon pox lesions or ectoparasites. In six birds receiving 
conscious blood sampling, not enough blood was obtained to perform all tests. No adverse 215 
events occurred during the health screen. 
 
     Five birds, from two collections, were positive for T. gallinae: one at initial swabbing, 
three at 24 hours and one after 96 hours of incubation. Age ranged from 1 month 18 days to 
12 years 7 months. One recently fledged female and one older male were in suboptimal body 220 
condition. No other pathogens were identified in these two birds. A budding yeast 
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overgrowth occurred in 5/42 TV pouches after 24 hours of incubation. Two positive pouches 
had a high bacterial load and therefore re-inoculation into a fresh TV pouch was performed at 
day five to increase chances of protozoal survival. Positive TV pouches were submitted for 
genotyping. Despite re-inoculation, bacterial contamination was still present, rendering them 225 
inadequate for genotyping. Of the remaining three samples, two died after stabilate 




     Performing a DRA in order to inform pre-export disease screening is a valuable way to 
minimize disease risks involved in translocating animals from ex situ populations. Previous 
reintroductions illustrate the detrimental effects that anthropogenic movement of animals can 
have, such as the accidental introduction of Batrachochytrium dendrobatidis into the native 
Mallorcan ecosystem by reintroduction of captive bred midwife toads (Alytes muletensis).81  235 
A literature search is a commonly utilized tool for creating a DRA,21,46,53,65 but historically 
DRAs have not always incorporated prospective data from health screening the source 
population. This may be due to debate between those who prefer minimal intervention and 
handling of captive wild animals, and those who would rather take a more proactive approach 
to screening populations involved in translocations. A balance needs to be reached between 240 
the potential stress and injury caused by the screening process, and the risk of subclinical 
disease going undiagnosed.  In this health screen, sampling coincided with routine health 
examinations, nail trimming or aviary moves, and therefore, not all birds in the EEP 
population were screened.  
 245 
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     Performing a health screen of the source population was a high priority for several 
reasons. Firstly, EEP pink pigeons are commonly raised by foster parents, usually Barbary 
doves (Streptopelia risoria), and adults are kept in outdoor aviaries, often in mixed species 
exhibits.72 This results in frequent interactions with other avian species, including wild birds, 
and more potential encounters with exotic pathogens. Cross-species transmission of parasites 250 
from free-ranging birds to those in captive zoo environments has been reported.19 
Additionally, they are not housed in biosecure aviaries, so staff could inadvertently play a 
role in disease transmission. Secondly, a prolonged pre-export quarantine period for disease 
screening is not a viable option. Trauma in pink pigeons is one of the leading causes of 
mortality.68 Combined with the preference to export young birds, at a certain time of the year, 255 
there is a desire to keep the quarantine period short with minimal repeated handling. 
Extensive, repeated screening of birds may cause delays or injuries, which could result in 
failure of translocation or compromise welfare. Thirdly, by screening the population, 
intermittently shed parasites are more likely to be detected. This is of high importance given 
the negative fitness effects of inbreeding depression, meaning the recipient population likely 260 
has an elevated susceptibility to disease.55,69,79 Finally, health screening the source population 
adds an increased evidence-base to the DRA, allowing production of a more targeted pre-
export screening protocol. 
 
     The most frequently encountered pathogen was T. gallinae, with five positive samples 265 
detected by the TV pouch method. A similar method, the InPouch Tritrichomonas foetus 
culture pack (TF pouch) has been used previously in free-living pink pigeons.15 The TV/TF 
pouch methods are more sensitive than wet-mount methods for detection of trichomonads,9,54 
with the TF pouch detecting over twice as many positive infections in pink pigeons.15 The 
results from this health screen support this, with 4/5 samples being positive for trichomonads 270 
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only after incubation. The TV pouch is designed for human use, with medium selective for 
trichomonad growth whilst inhibiting yeasts, fungi and bacteria. After 24 hours of incubation 
five pouches had yeast overgrowth and two bacterial overgrowth. It is possible the inhibitory 
agents in the medium are not very effective against avian bacteria and yeasts. No 
trichomonads were found in pouches with yeast overgrowth, questioning whether this could 275 
have inhibited T. gallinae growth. Both pouches with bacterial overgrowth were positive for 
T. gallinae, but one only after 96 hours. It is possible that the presence of bacteria competing 
for the nutritive medium slowed protozoal growth in this pouch. 
 
     Genotyping of T. gallinae performed on samples from a diverse range of birds in the UK 280 
has identified both pathogenic and apathogenic strains.3,20,49 Of the five positive T. gallinae 
cultures, genotyping was successfully performed on one sample, confirming a C strain, which 
is believed to be apathogenic.3 The other positive cultures were bacterially contaminated or 
died, preventing further analysis. In future when genotyping, it would be advisable to retain 
subcultures of the original sample. If bacterial contamination is present, subculture using a 285 
different medium, supplemented with antibiotics could be considered. Investigation into the 
effects of yeast on trichomonad growth in the TV pouch would give further insight into the 
reliability of this screening method. 
 
     Trichomonosis can cause lesions in the digestive and upper respiratory tracts leading to 290 
starvation, asphyxiation and death. No visible lesions were seen in the positive birds, but two 
were in suboptimal body condition. The low body condition of these two birds, one recently 
fledged female and one breeding male, could have been related to their T. gallinae infection. 
However, other husbandry factors or non-infectious diseases leading to a reduction in food 
intake may also have contributed, such as poor care by foster parents during the neonatal 295 
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period, or aggression whilst paired for breeding, both of which have been reported in this 
species.68,72 In a retrospective mortality review of 404 European captive pink pigeons only 
one death was attributed to trichomonosis.68 This contrasts with a mortality review of the 
free-living population which reported 52% of deaths (22/43) attributed to this parasite.17 It is 
possible that a more virulent T. gallinae strain exists in Mauritius, but the Mauritian pink 300 
pigeon population could also be less resistant to disease.17,74 Genotyping of the T. gallinae 
present in Mauritius may further add to our understanding of the pathogenesis of this disease 
in the free-living population. 
 
     Yersinia spp. culture was performed to screen for Y. pseudotuberculosis. Within the 305 
Yersinia genus, only three species are recognised as pathogenic: Y. enterocolitica, Y. pestis 
and Y. psuedotuberculosis.2 Clinical signs in birds include lethargy, anorexia, diarrhea, 
respiratory distress, emaciation and sudden death.30 Y. pseudotuberculosis is seasonal, with 
most clinical cases occurring in winter.30,68 Screening took place from January to April, when 
this bacteria would most likely be present. Y. pseudotuberculosis is most reliably cultured 310 
from organs demonstrating lesions. Fecal culture may also be performed, however shedding 
can be intermittent. PCR may be a more reliable method for detecting carrier status, however 
this test was not available in the UK at the time of screening. Although three birds screened 
positive for Yersinia spp. these were not considered pathogenic. One report details Yersinia 
kristensenii as pathogenic in iron-treated mice, but there are no reports of it being a natural 315 
pathogen.63 
 
     Unsporulated coccidial oocysts were found in three birds. Sixteen named species of 
Eimeria have been reported in Columbiformes,8 for which pathogenicity is debatable as 
coccidian parasites are found in healthy birds.35 Under stressful periods coccidian oocysts can 320 
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be shed in large numbers and lead to clinical disease, with young birds being particularly 
susceptible. Evidence shows that exposure to coccidia can help produce immunity, which 
may be beneficial if later exposed to more pathogenic strains.35 Apart from the recent 
identification of Eimeria mauritiensis in the pink pigeon, no coccidian parasites have so far 
been reported in Columbiformes on Mauritius,8 despite the presence of four other 325 
Columbiform species.16 Therefore, the Mauritian pink pigeon population may have had 
minimal exposure to coccidian parasites, resulting in poor immunity. The three positive 
individuals in this study showed no signs of clinical disease. However, translocated birds will 
undergo transportation, further quarantine and then be released into captive breeding 
facilities, all of which could increase stress levels and shedding of oocysts. They may have 330 
contact with immunologically naive squabs, and since coccidian parasites have a direct life 
cycle and rapid intracellular multiplication, this could be detrimental to the breeding colony. 
With the knowledge that individuals are asymptomatically carrying coccidian parasites and 
that pre-export screening may fail to detect infection due to intermittent shedding, 
prophylactic treatment prior to export should be considered. 335 
 
     Strongyle ova were found in three birds. In low numbers, these are not clinically 
significant, and there are many reports of avian species, including Columbiformes, positive 
on routine screening.19,40,66 No clinical disease was seen, but transportation stressors could 
cause increased shedding and build-up of this parasite. 340 
 
     Hemoparasite screening was a priority as  L. marchouxi infection has been found in 
Columbiformes, and has caused a reduction in survival of pink pigeons.14,76 Hemoparasites 
have been noted to affect host populations by reducing reproductive success51 and immune 
response,52,78 and chronic persistent infection can cause long-term accumulative effects which 345 
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impair fitness.5 All birds screened negative for hemoparasites via PCR and microscopic 
examination of blood films. PCR was used as well as microscopy as it has a higher 
sensitivity43,80 and reduces the likelihood of missing a low-level parasitemia, which is often 
found in chronically infected birds.10  False negatives can occur even with PCR due to 
parasite DNA being present at very low concentrations in DNA samples of the hosts, 350 
resulting in intermittent parasite amplification. To minimise the risk of false negatives, 
samples were screened at least twice. This study spanned over a 10-month period, but 
screening was performed predominantly during winter months. Previous reports suggest a 
correlation between hemoparasite infection and vector density,47 which may suggest winter 
sampling, when vector numbers are low in the UK and Channel Islands, may not be 355 
representative of parasitemia during all seasons. However, recent studies suggest that 
hemoparasites can persist in winter, possibly due to relapse of infection, and in wild birds, 
infections may be even more severe at this time than in the breeding season.28,42 
 
     Pigeon adenovirus is an important infectious disease but was not screened due to lack of 360 
availability and limitations of commercial tests in the UK. Pigeon circovirus, pigeon 
herpesvirus, PPMV-1, APMV-1, C. psittaci, M. avium and Salmonella spp. were not detected 
during screening. Despite these tests being negative, results will be influenced by the 




     This health screen was performed to identify potential pathogens currently present in the 
EEP pink pigeon population. Together with information from a retrospective mortality 
review68 and literature search, these findings will contribute to a DRA and creation of an 370 
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evidence-based, practical pre-export protocol for translocation of EEP pink pigeons to 
Mauritius. Although none of the potential pathogens detected were causing overt clinical 
signs, given the susceptibility of the free-living population to disease, these results are still 
valuable. Performing a similar health screen on the free-living Mauritian population would 
further our understanding of disease susceptibility and exposure of this population. Not only 375 
would this further guide the pre-export protocol, but as captive bred EEP pink pigeons will 
have different immunological challenges and pathogen exposure to that of the free-living 
population, it would help to determine effective preventative medicine protocols to safeguard 
the translocated animals. 
 380 
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Table 1: Infectious diseases of Columbiformes that formed part of EEP captive pink pigeon 620 
(Nesoenas mayeri) health screening: tests, samples required and screening laboratory 







Pigeon circovirus PCRa Cloacal swab Animal Geneticse 42 0 















& cloacal swab 








& cloacal swab 
Animal Geneticse 42 0 





Culture Cloacal swab or 3-day 
pooled fecal 
 





Cloacal swab or 3-day 
pooled fecal 
 
Greendalei 21 3 
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Trichomonas gallinae Culture (TV 
pouch)d 
 
Crop swab In-house laboratoryg,h 42 5 
Genotyping 
 






100µl whole blood in 
96% ethanol 
 
UEAk 42 0 
Microscopy Blood smear In-house laboratoryg 
 
42 0 
Endoparasites Zinc sulphate 
flotation 
 




N/A N/A 42 0 
Pigeon poxvirus Visual 
examination 
N/A N/A 42 0 
aPolymerase chain reaction 
bHemagglutination-Inhibition test 
cImmunocomb: Avian Chlamydophila Psittaci Ab. Test Kit (Biogal Galed Labs Asc Ltd., Kibbutz Galed, 1924000, Israel) 
dInPouch® Trichomonas vaginalis culture kit (BioMed Diagnotics, Inc. 1388 Antelope Rd, White City, Oregon, 97503, 625 
USA) 
eAnimal Genetics: St Austell, Cornwall, PL25 3LB, UK 
fAnimal and Plant Health Agency, Weybridge, Surrey, KT15 3NB, UK 
gTests were performed at Bristol Zoo Gardens, Clifton, Bristol BS8 3HA, UK 
hTests were performed at Durrell Wildlife Conservation Trust, Les Augrès Manor, La Profonde Rue, Trinity, Jersey, 630 
Channel Islands, JE3 5BP 
iGreendale Veterinary Diagnostics Limited, Woking, GU21 2EP, UK 
jTesting performed by Dr K. M. Tyler, Norwich Medical School (BMRC), University of East Anglia, Norwich, NR4 7TJ, 
UK 
kTesting performed by David S Richardson, Professor in Evolutionary Ecology and Conservation, School of Biological 635 
Sciences, Norwich Research Park, University of East Anglia, Norwich, NR4 7TJ, UK 
